Cargando…

Corrigendum: RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond

Detalles Bibliográficos
Autores principales:	Liu, Xiaoyu, Tang, A-Ling, Chen, Jie, Gao, Nan, Zhang, Guoqiang, Xiao, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679724/ https://www.ncbi.nlm.nih.gov/pubmed/38022601 http://dx.doi.org/10.3389/fimmu.2023.1332633

Ejemplares similares

RIPK1 in the inflammatory response and sepsis: Recent advances, drug discovery and beyond
por: Liu, Xiaoyu, et al.
Publicado: (2023)

KW2449 ameliorates collagen-induced arthritis by inhibiting RIPK1-dependent necroptosis
por: Wang, Qiong, et al.
Publicado: (2023)

Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases
por: Pham, Anh-Tuan, et al.
Publicado: (2023)

RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features
por: Sultan, Mutaz, et al.
Publicado: (2022)

RIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
por: Barbosa, Laiana A., et al.
Publicado: (2018)

RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
por: Ke, Dan, et al.
Publicado: (2023)

Corrigendum: Recent Advances on Nutrition in Treatment of Acute Pancreatitis
por: Pan, Li-Long, et al.
Publicado: (2018)

Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection
por: Norton, Thomas D., et al.
Publicado: (2016)

RIPK1-Associated Inborn Errors of Innate Immunity
por: Zhang, Jiahui, et al.
Publicado: (2021)

Corrigendum: Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine
por: Melgoza-González, Edgar Alonso, et al.
Publicado: (2023)

m6A modification: recent advances, anticancer targeted drug discovery and beyond
por: Deng, Li-Juan, et al.
Publicado: (2022)

Targeting RIPK1 kinase for modulating inflammation in human diseases
por: Li, Wanjin, et al.
Publicado: (2023)

Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death
por: Frank, Daniel, et al.
Publicado: (2022)

Comprehensive Evolutionary Analysis of Lamprey TNFR-Associated Factors (TRAFs) and Receptor-Interacting Protein Kinase (RIPKs) and Insights Into the Functional Characterization of TRAF3/6 and RIPK1
por: Hou, Jianqiang, et al.
Publicado: (2020)

Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury
por: Xia, Kaijiang, et al.
Publicado: (2020)

Recent advances in phenotypic drug discovery
por: Swinney, David C., et al.
Publicado: (2020)

Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023)

Corrigendum: Construction and validation of a robust prognostic model based on immune features in sepsis
por: Zheng, Yongxin, et al.
Publicado: (2023)

Recent advances in exosome-based immunotherapy applied to cancer
por: Xie, Jindong, et al.
Publicado: (2023)

microRNA-210 and microRNA-3570 Negatively Regulate NF-κB-Mediated Inflammatory Responses by Targeting RIPK2 in Teleost Fish
por: Su, Hui, et al.
Publicado: (2021)

Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut
por: Garcia-Carbonell, Ricard, et al.
Publicado: (2019)

O-GlcNAcylation of RIPK1 rescues red blood cells from necroptosis
por: Seo, Junghwa, et al.
Publicado: (2023)

Recent advances in combinatorial biosynthesis for drug discovery
por: Sun, Huihua, et al.
Publicado: (2015)

Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis
por: Hou, Jue, et al.
Publicado: (2019)

Corrigendum: RIPK3: A New Player in Renal Fibrosis
por: Shi, Ying, et al.
Publicado: (2021)

Advances in RIPK1 kinase inhibitors
por: Chen, Lu, et al.
Publicado: (2022)

Corrigendum: A theoretical framework of immune cell phenotypic classification and discovery
por: Hu, Yuzhe, et al.
Publicado: (2023)

Discovery of a cooperative mode of inhibiting RIPK1 kinase
por: Meng, Huyan, et al.
Publicado: (2021)

Corrigendum: Targeting Complement Pathways in Polytrauma- and Sepsis-Induced Multiple-Organ Dysfunction
por: Karasu, Ebru, et al.
Publicado: (2019)

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014)

Phosphorylation of RIPK1 serine 25 mediates IKK dependent control of extrinsic cell death in T cells
por: Blanchett, Sam, et al.
Publicado: (2022)

Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies
por: Cifaldi, Cristina, et al.
Publicado: (2019)

Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: recent developments and future perspectives
por: Plichta, Jacek, et al.
Publicado: (2023)

Autoantibody Discovery, Assay Development and Adoption: Death Valley, the Sea of Survival and Beyond
por: Fritzler, Marvin J., et al.
Publicado: (2021)

Recent Advances in Prostate Cancer Treatment and Drug Discovery
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2018)

Recent Strategic Advances in CFTR Drug Discovery: An Overview
por: Rusnati, Marco, et al.
Publicado: (2020)

Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
por: Lai, Yurong, et al.
Publicado: (2022)

Corrigendum: Corticosteroids for Treating Sepsis in Adult Patients: A Systematic Review and Meta-Analysis
por: Liang, Huoyan, et al.
Publicado: (2021)

Inflammatory Bowel Disease Therapy: Beyond the Immunome
por: Fiocchi, Claudio, et al.
Publicado: (2022)

Recent Advances in Immune Cell Therapy for Glioblastoma
por: Kang, Xianhui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_erogn8mf49voe8dlcm91equjh5